Status:
NOT_YET_RECRUITING
Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Lead Sponsor:
Fudan University
Conditions:
Peripheral Arterial Disease
Perfusion
Eligibility:
All Genders
18-80 years
Brief Summary
We investigate the peri-operative foot perfusion through dynamic contrast enhanced MRI in patients with peripheral artery disease
Eligibility Criteria
Inclusion
- 18 to 80 years old;
- PAD patients with Fontaine grade II-IV or Rutherford grade 2-6 and underwent a successful revascularization;
- Patients completed both pre- and post-operative MRI workups;
- Patients signed the informed consent form and be able to complete the clinical follow-up for 1 months.
Exclusion
- Patients has participated in other clinical studies;
- Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/ severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate\<60 ml/min)
- Any allergic constitution;
- Pregnancy and childbirth;
- Life expectancy\<12 months.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06525415
Start Date
August 1 2024
End Date
November 30 2024
Last Update
July 29 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.